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Abstract. The effects of 26 trihaloacetylazulene derivatives on
nitric oxide (NO) production by the mouse macrophage-like Raw
264.7 cells was investigated. The trichloroacetylazulenes [1b-13b]
generally showed higher cytotoxicity as compared with the
corresponding trifluoroacetylazulenes [1a-13a]. All the
compounds inhibited NO production by lipopolysaccharide
(LPS)-activated Raw 264.7 cells to various extents. 3-Trifluoro-
acetylguaiazulene [8a], 1-trifluoroacetyl-4,6,8-trimethylazulene
[10a], 3-methyl-1-trichloroacetylazulene [2b] and 3-ethyl-1-
trichloroacetylazulene [3b] showed lower cytotoxic activity and
most effectively inhibited NO production. Western blot analysis
revealed that compounds [8a, 10a] dose-dependently reduced the
intracellular concentration of inducible NO synthase (iNOS),
whereas compounds [2b, 3b] only marginally affected the iNOS
protein expression. RT-PCR analysis showed that compounds [8a,
2b] reduced the iNOS mRNA expression by approximately 50%.
These compounds affected cyclooxygenase-2 protein and mRNA
expression, depending on the concentrations. ESR spectroscopy
revealed that compounds [8a, 10a, 2b, 3b] neither produced
radical, nor scavenged NO, superoxide anion or diphenyl-2-
picrylhydrazyl radicals. The present study showed the inhibitory
effects of trifluoroacetylazulenes and trichloroacetylazulenes on NO
production by activated macrophages.
Azulene (1-4), an isomer of naphthalene, has a dipole moment
and a resonance energy with intermediate values between those
of benzene and naphthalene, and is considerably more reactive
when compared with two arenes. Azulene derivatives have been
investigated for their synthesis and chemical reactions (5-7).
These derivatives have shown several biological activities,
including antibacterial activity (8), anti-ulcer activity (9),
relaxant activity (10), inhibition of thromboxane A2-induced
vasoconstriction and thrombosis (11), acute toxicity and local
anesthetic activity (12), and chemotherapeutic activity against
mucous membrane diseases (13, 14). Since the effects of
azulene derivatives on cellular function have not yet been
investigated in detail, the structure-activity study of azulene,
tropolone and azulenequinone-related compounds was initiated
(15-20). Among 81 compounds analyzed to date, 2-acetyl-
aminoazulene, diethyl 2-chloroazulene-1,3-dicarboxylate, methyl
7-isopropyl-2-methoxyazulene-1-carboxylate (16), tropolone
derivatives with the phenolic OH group, hinokithiol, its tosylate
and methyl ethers (18), 3-(3-guaiazulenyl)-1,5-azulenequinone
and 7-isopropyl-3-(4-methylanilino)-2-methyl-1,5-azulenequi-
none (20) showed relatively higher tumor-specific cytotoxic
activity. 1,3-Difluoroazulene (15), 2,4-dibromo-7-methoxy-
tropone (17), 3-morpholino-1,5-azulenequinone and 3,7-
dibromo-1,5-azulenequinone (19) inhibited nitric oxide (NO)
production by lipopolysaccharide (LPS)-activated mouse
macrophages, without (15) or with (17, 19) the inhibition of
inducible NO synthase (iNOS) mRNA and protein expression.
We recently found that trichloroacetylazulenes [1b-13b]
(Figure 1) generally showed higher cytotoxicity and higher
tumor-specific cytotoxicity as compared with the corresponding
trifluoroacetylazulenes [1a-13a] (Figure 1). Especially, 2,3-
dimethyl-1-trichloroacetylazulene [5b] and 1,3-ditrichloro-
acetyl-4,6,8-trimethylazulene [11b] showed the highest
cytotoxicity and tumor-specificity (TS >35.6 and >44.1,
respectively) (21). Whether these 26 trihaloacetylazulene
derivatives, like azulenes (15), tropolones (17) and
azulenequinones (19), inhibit NO production by unstimulated-
and LPS-stimulated mouse macrophage-like Raw 264.7 cells
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was investigated and their effects on NO anabolism (iNOS
protein and mRNA expressions, assessed by Western blotting
and RT-PCR analyses) and catabolism (NO scavenging activity,
assessed by ESR spectroscopy) were also examined. To
investigate the possible anti-inflammatory activity of the
trihaloacetylazulenes, their effect on the expression of
cyclooxygenase-2 (COX-2), which is induced by inflammation
and is invoved in the production of PGE2 (22), was also studied.
Materials and Methods
Materials. The following chemicals and reagents were obtained from
the indicated companies: Dulbecco's modified Eagle medium
(DMEM), phenol red-free DMEM (Gibco BRL, Grand Island, NY,
USA); fetal bovine serum (FBS) (JRH Bioscience, Lenexa, KS, USA);
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
dimethyl sulfoxide (DMSO) (Wako Pure Chem. Ind., Ltd., Osaka,
Japan); LPS from Escherichia coli. (Serotype 0111:B4), hypoxanthine
(HX), xanthine oxidase (XOD), diethylenetriamine-pentaacetic acid
(DETAPAC), diphenyl-2-picrylhydrazyl (DPPH), phenylmethylsulfonyl
fluoride (PMSF) (Sigma Chem. Co., St. Louis, MO, USA); 5,5-
dimethyl-1-pyrroline-N-oxide (DMPO), 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimi-dazoline-1-oxy1-3-oxide (carboxy-PTIO, a spin trap
agent), 1-hydroxy-2-oxo-3-(N-3-methyl-3-aminopropyl)-3-methyl-1-
triazene (NOC-7, a NO generator) (Dojin, Kumamoto, Japan). 
Synthesis of trihaloacetylazulenes. The trihaloacetylazulene derivatives
were synthesized, according to the published methods for the following
compounds: 1-trifluoroacetylazulene [1a] (23, 24), 3-methyl-1-
trifluoroacetylazulene [2a] (25), 3-ethyl-1-trifluoroacetyl-azulene [3a]
(24-26), 2-methyl-1-trifluoroacetylazulene [4a] (25), 2,3-dimethyl-1-
trifluoroacetylazulene [5a] (24-26), 7-isopropyl-3-methyl-1-trifluoro-
acetylazulene [6a] (24-26), 3-ethyl-7-isopropyl-1-trifluoroacetylazulene
[7a] (24-26), 3-trifluoroacetylguaiazulene [8a] (26, 27), 6-isopropyl-2-
methyl-1-trifluoroacetylazulene [9a] (24-26), 1-trifluoroacetyl-4,6,8-
trimethylazulene [10a] (26, 27), 1,3-ditrifluoroacetyl-4,6,8-trimethyl-
azulene [11a] (28-30), 1,3-ditrifluoro-acetylazulene [12a] (28-30), 
2-methyl-1,3-ditrifluoroacetylazulene [13a] (28-30), 1-trichloroacetyl-
azulene [1b] (24), 3-methyl-1-trichloroacetylazulene [2b] (24-26), 3-
ethyl-1-trichloroacetylazulene [3b] (24-26), 2-methyl-1-trichloro-
acetylazulene [4b] (24-26), 2,3-dimethyl-1-trichloroacetylazulene [5b]
(24-26), 7-isopropyl-3-methyl-1-trichloroacetylazulene [6b] (24-26), 
3-ethyl-7-isopropyl-1-trichloroacetylazulene [7b] (24-26), 3-trichloro-
acetylguaiazulene [8b] (26), 6-isopropyl-2-methyl-1-trichloroacetyl-
azulene [9b] (24-26), 1-trichloroacetyl-4,6,8-trimethylazulene [10b]
(26), 1,3-ditrichloro-acetyl-4,6,8-trimethylazulene [11b] (28-30), 1,3-
ditrichloroacetylazulene [12b] (28-30), 2-methyl-1,3-ditrichloro-
acetylazulene [13b] (28-30).
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Figure 1. Chemical structures of the trifluoroacetylazulenes [1a-13a] and trichloroacetylazulenes [1b-13b]. 
Cell culture. The mouse macrophage-like Raw 264.7 cells were
cultured in DMEM supplemented with 10% heat-inactivated FBS
under a humidified 5% CO2 atmosphere (15, 17, 19).
Assay for cytotoxic activity. The cytotoxic activity of the azulenes was
determined by the MTT method and was expressed as the absorbance
at 540 nm of the MTT-stained cells. The 50% cytotoxic concentration
(CC50) was determined from the dose-response curve (15, 17, 19).
Assay for NO concentration. Near confluent Raw 264.7 cells were
incubated for 24 h with each test sample in phenol red-free DMEM
supplemented with 10% FBS, and the NO production by Raw 264.7
cells was quantified by Greiss reagent, using the standard curve of
NO2–. To eliminate the interaction between the sample and the
Greiss reagent, the NO concentration in the culture medium without
the cells was also measured, and this value was subtracted from that
obtained with the cells. The concentration that inhibited the LPS-
stimulated NO production by 50% (50% inhibitory concentration:
IC50) was determined from the dose-response curve (15, 17, 19). The
efficacy of inhibition of NO production was evaluated by the
selectivity index (SI), which was calculated by the following equation:
SI=CC50 / IC50.
Western blotting. The cell pellets were lysed with 100 ÌL of lysis buffer
(10 mM Tris-HCl, pH 7.6, 1% Triton X-100, 150 mM NaCl, 5 mM
EDTA and 2 mM PMSF) for 10 min in ice water and were then
incubated for 50 min at 4ÆC with RT-5 ROTATOR (Titec, Saitama,
Japan). The cell lysates were centrifuged at 16,000 xg for 20 min at 4ÆC
to remove the insoluble material and the supernatant was collected.
The protein concentrations of the supernatant was measured using the
Protein Assay Kit (Bio Rad, Hercules, CA, USA). An equal amount
of the protein from the cell lysates (10 Ìg) was mixed with 2 x sodium
dodecyl sulfate (SDS)-sample buffer (0.1 M Tris-HCl, pH 6.8, 20%
glycerol, 4% SDS, 0.01% bromphenol blue, 1.2% 2-mercaptoethanol),
boiled for 10 min, applied to SDS-8% polyacrylamide gel
electrophoresis and then transferred to polyvinylidene difluoride
(PVDF) membrane. The membranes were blocked with 5% skim milk
in phosphate-buffered saline [PBS(–)] plus 0.05% Tween 20 for 90 min
and were incubated with anti-iNOS antibody (1:1,000, Santa Cruz
Biotechnology, Delaware, CA, USA), anti-COX-2 antibody (1:1,000,
Santa Cruz), or anti-actin antibody (1:2000-4000, Sigma) for 90 min at
room temperature, followed by incubation with horseradish peroxidase-
conjugated anti-mouse or goat IgG for 90 min at room temperature.
∆he immunoblots were developed with Western Lightningì
Chemiluminescence Reagent Plus (Perkin Elmer Life Sciences,
Boston, MA, USA) and were analyzed on a Macintosh (Power
Macintosh 7600/120) computer using the public domain NIH Image
program (National Technical Information Service, Springfield, VA,
USA, part number PB95-500195GEI). 
Assay for mRNA expression. Total RNA was isolated using the
PURESCRIPT RNA Isolation kit (Gentra systems) protocol. Raw
264.7 cells were lysed in 300 ÌL cell lysis solution, followed by the
addition of 100 ÌL Protein-DNA precipitation solution. The cell
lysates were centrifuged at 15,000 xg for 3 min. To the supernatant,
300 ÌL isopropanol were added. After centrifuging at 15,000 xg for 
3 min, the pellet was washed in 300 ÌL 75% ethanol. Following further
centrifugation at 15,000 xg for 1 min, the pellet was air dried for 15
min and dissolved in DEPC-treated H2O. A reverse transcriptase
reaction (RT) was performed with 1.0 Ìg of total RNA, using the
Rever Tra Ace (Toyobo Co., Ltd., Japan) with oligo (dT)20 primer
(15, 17, 19). Single-strand cDNA obtained by the RT reaction was
amplified, using the KOD plus (Toyobo Co.), iNOS specific primers
(5’-CCCTTCCGAAGTTTCTGGCAGCAGC-3’ and 5’-GGCT
GTCAGAGCCTCGTGGCTTTGG-3’), COX-2 specific primers 
(5'-TTTGTTGAGTCATTCACCAGACAG-3' and 5'-CAGTATT
GAGGAGAACAGATGGGATT-3') and ‚-actin specific primers
(5'-GAGGCCCAGAGCAAGAGAGG-3', 5'-TACATGGCTGGGG
TGTTGAA-3'), according to the protocol. The RT-PCR products
were applied to 2% agarose gel, the ethidium bromide-stained gel was
then photographed under UV light and analyzed as described above.
Radical scavenging activity. The radical intensity of the trihalo-
acetylazulenes was determined at 25ÆC, using ESR spectroscopy
(JEOL JES REIX, X-band, 100 kHz modulation frequency) (15, 17,
19). The compounds (8 mM dissolved in DMSO) were mixed with an
equal volume of 0.2 M sodium phosphate buffer (PB) (pH. 4.0), 
0.2 M Tris-HCl (pH 7.4), 0.1 M Na2CO3/NaHCO3 buffer (pH 10.0)
or 0.2 M KOH (pH 13.5). The radical intensity was measured 40 sec
thereafter (center field, 336.0±5.0 mT; microwave power, 12 mW;
modulation amplitude, 0.1 mT: gain, 500, time constant, 0.1 sec;
scanning time, 4 min). 
The radical intensity of NO, produced from the reaction mixture
of 20 ÌM carboxy-PTIO and 50 ÌM NOC-7, was determined in 0.1 M
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Table I. Inhibition of NO production by LPS-stimulated Raw 264.7 cells
in trihaloacetylazulenes.
Compound MW. CC50 (ÌM) IC50 (ÌM) SI
(–)LPS (+)LPS (+)LPS
[1a] 224 323.2 321.6 21.5 15.0±2.8 
[2a] 238 >500.0 >500.0 30.1 >16.6±6.1 
[3a] 252 >500.0 >500.0 52.9 >9.4±6.6 
[4a] 238 281.4 >340.8 109.6 >3.1±3.6 
[5a] 252 >500.0 >500.0 107.4 >4.7±1.7 
[6a] 280 >411.8 >375.6 55.9 >6.7±3.5 
[7a] 294 239.8 164.9 29.3 5.6±2.0 
[8a] 294 >408.0 >400.5 16.6 >24.2±5.1 
[9a] 280 412.4 365.0 101.2 3.6±2.0 
[10a] 266 >500.0 >500.0 22.1 >22.7±10.3 
[11a] 362 >500.0 >500.0 34.1 >14.7±2.6 
[12a] 320 >500.0 >500.0 86.5 >5.8±2.1 
[13a] 334 >344.3 >195.9 39.7 >4.9±4.3 
[1b] 273.5 51.1 53.9 8.7 6.2±0.9 
[2b] 287.5 >494.6 >500.0 13.3 >37.7±6.6 
[3b] 301.5 >500.0 >500.0 13.9 >36.1±2.7 
[4b] 287.5 82.3 67.3 22.0 3.1±3.1 
[5b] 301.5 19.7 12.3 9.2 1.3±1.2 
[6b] 329.5 >218.7 92.2 13.3 6.9±3.5 
[7b] 343.5 120.7 101.0 9.5 10.7±3.4 
[8b] 343.5 17.0 19.5 4.7 4.2±2.8 
[9b] 329.5 67.7 60.2 14.3 4.2±1.5 
[10b] 315.5 9.9 10.0 <2.0 >5.1±0.9 
[11b] 461 3.0 <2.0 <2.0 ><1.0±0.0 
[12b] 419 136.0 >232.3 24.0 >9.7±3.4 
[13b] 433 >217.3 68.7 11.1 6.2±3.5
Each value represents the mean±S.D. from three to six independent
experiments.
PB, pH 7.4, in the presence of 30% DMSO. When NOC-7 (NO
generator) and carboxy-PTIO (spin trapping agent) were mixed, NO
was oxidized to NO2 and carboxy-PTIO was reduced to carboxy-PTI,
which produce seven-line signals. The NO radical intensity was
defined as the ratio of signal intensity of the first peak of carboxy-PTI
to that of MnO (15, 17, 19) and was expressed as the ratio to the
height of MnO, an external marker. 
For determination of the superoxide anion (O2–) produced by HX
and XOD reactions (total volume: 200 ÌL) [2 mM HX in 0.1 M PB
(pH 7.4) 50 ÌL, 0.5 mM DETAPAC 20 ÌL, 8% DMPO 30 ÌL,
sample compound (7.5 mM in DMSO) 40 ÌL, H2O or SOD 30 ÌL,
XOD (0.5 U/mL in PB) 30 ÌL], the gain was changed to 400. The O2–
scavenging activity was expressed as the ratio of the intensity of the
first peak of DMPO-OOH to that of MnO.
For the determination of the DPPH radical scavenging activity, the
compound was mixed with the reaction mixture (total volume: 
200 ÌL) [100 ÌM DPPH 140 ÌL, H2O 20 ÌL, sample in DMSO 40 ÌL]
and, after 1 min, was subjected to ESR spectroscopy (31). 
Results
Structure and activity relationship. The 13 trichloro-
acetylazulenes [1b-13b] generally showed higher cytotoxicity
against the Raw 264.7 cells, compared to the corresponding
13 trifluoroacetylazulenes [1a-13a] (Table I). All of these
compounds failed to stimulate the Raw 264.7 cells to produce
detectable amounts of NO, but inhibited the NO production
by LPS-activated Raw 264.7 cells to various extents (Table I).
Compounds [8a, 10a, 2b, 3b], with lesser cytotoxic activity
(CC50=>400, >500, >500 and >500 ÌM, respectively),
inhibited NO production to the greatest extent (IC50=16.6,
22.1, 13.3 and 13.9 ÌM, respectively) (Figure 2), producing the
highest selectivity index (SI)= >24.2, >22.7, >37.7 and
>36.1, respectively (Table I). 
Effect on iNOS expression. Western blot analysis showed that
compounds [8a, 10a] dose-dependently reduced the
intracellular concentration of inducible NO synthase (Figure
3A, 3B), overlapping the dose-response curve of inhibition
of NO production (Figure 2A, 2B). On the other hand,
compounds [2b, 3b] slightly increased the iNOS protein
expression at lower concentrations (3-13 ÌM), but were
weakly inhibitory at higher concentrations (27-56 ÌM)
(Figure 3C, 3D). RT-PCR analysis showed that the
inhibition of iNOS mRNA expression by compounds [8a,
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Figure 2. Effect of trihaloacetylazulenes on the NO production by LPS-stimulated Raw 264.7 cells. Near-confluent Raw 264.7 cells were incubated for
24 h with the indicated concentrations of 3-trifluoroacetylguaiazulene [8a] (A), 1-trifluoroacetyl-4,6,8-trimethylazulene [10a] (B), 3-methyl-1-
trichloroacetylazulene [2b] (C) or 3-ethyl-1-trichloroacetylazulene [3b] (D) in the absence (■, ◆) or presence (■, ◆) of 100 ng/mL LPS in phenol red-
free DMEM supplemented with 10% FBS, and then the viable cell number (expressed as % of control) (■, ■) and extracellular concentration of NO
(◆, ◆) were determined by MTT assay and Griess reagent, respectively. Each value represents the mean from three independent experiments.
2b] was incomplete, with only a 50% reduction of iNOS
mRNA expression (Figure 4). 
Radical production and scavenging activity. ESR spectroscopy
revealed that compounds [8a, 10a, 2b, 3b] did not produce
any detectable amounts of radical at wide ranges of pH (pH
4.0-13.5) (Table II). Solutions of compounds [2b, 3b] at pH
10 became turbid, but upon elevation of the pH to 13.5, the
solutions became clear again but the color changed to blue.
Compounds [8a, 10a, 2b, 3b] (1.5 mM) only slightly reduced
the NO radical intensity (at most 10-17%), but did not scavenge
the O2
– radical at all. All these compounds (4 mM) only slightly
reduced the DPPH radical (at most 5-33%) (Table II).
Relation between iNOS and COX-2 expression. The effects of
compounds [8a, 10a, 2b, 3b] on COX-2 protein expression
were more complicated and roughly biphasic: inhibition at
lower concentrations and stimulation at higher concentrations
(Figure 3). Compounds [8a, 2b] showed a similar biphasic
effect on COX-2 mRNA expression (Figure 4). 
Discussion
The present study demonstrated for the first time, that 13
trichloroacetylazulenes [1b-13b] generally showed higher
cytotoxicity against Raw 264.7 cells than the corresponding 13
trifluoroacetylazulenes [1a-13a], in agreement with the higher
cytotoxicity of the  trichloroacetylazulenes against human
tumor cell lines (21). Among a total of 26 compounds, [8a,
10a, 2b, 3b] most efficiently inhibited the NO production in
LPS-activated Raw 264.7 cells, with the highest selectivity index
(SI=>23->38). The NO concentration is influenced by both
the intracellular concentration and activity of iNOS protein
and quenching of the NO radical. The NO radical interacts
with superoxide anion (O2
–) (32). We found that compounds
[8a, 10a, 2b, 3b] only marginally scavenged the NO radical
(produced from NOC-7, a NO donor), even at 
1.5 mM, a 100-fold higher concentration that induced a 50%
reduction in the NO production by LPS-stimulated Raw 264.7
cells. Furthermore, none of these compounds increased O2
–,
known to interfere with NO. These data reduce the possibility
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Figure 3. Effect of trihaloacetylazulenes on the intracellular concentration of iNOS and COX-2 proteins in Raw 264.7 cells. Raw 264.7 cells were
incubated for 24 h with the indicated concentrations of 3-trifluoroacetylguaiazulene [8a] (A), 1-trifluoroacetyl-4,6,8-trimethylazulene [10a] (B), 3-methyl-
1-trichloroacetylazulene [2b] (C) or 3-ethyl-1-trichloroacetylazulene [3b] (D) in the presence of 100 ng/mL LPS. The cell lysate was applied to 
SDS-PAGE and iNOS (grey bars) or COX-2 (white bars) proteins were quantified by Western blot analysis, followed by densitometry. The intracellular
iNOS or COX-2 protein was expressed as the ratio to that of actin protein. The iNOS protein concentration without LPS was below the detection limit
and, therefore, omitted. Each value represents the mean from three independent experiments.
that inhibition of NO production by compounds [8a, 10a, 2b,
3b] is due to NO scavenging activity. Alternatively, we found
that compounds [8a, 10a] inhibited iNOS production at the
same concentration that inhibited NO production, indicating
that compounds [8a, 10a] inhibited NO production possibly
by inhibiting iNOS protein expression. Since compounds [8a,
10a] did not completely inhibit the iNOS mRNA expression,
the involvement of a post-transcriptional regulation mechanism
was suggested. On the other hand, compounds [2b, 3b] did not
affect the iNOS protein expression, indicating the possibility
that these compounds inactivate the iNOS protein.
Compounds [8a, 10a] did not completely inhibit COX-2
protein expression, but rather increased it at higher
concentrations, suggesting that iNOS and COX-2 expressions
are not correlated with each other. This may be partly
explained by the difference in the basal level and stimulation-
fold between iNOS and COX-2 expressions after LPS
stimulation. It was recently reported that COX-2 is activated
after nitrosylation by binding with iNOS at a specific binding
site (33). This suggests that the reduction of iNOS protein
expression in Raw 264.7 cells on treatment with compounds
[8a, 10a] might activate COX-2 less efficiently.
Our recent studies demonstrated that trihaloacetylazulene
derivatives show diverse biological activity. Although 
2,3-dimethyl-1-trichloroacetylazulene [5b] and 1,3-ditrichloro-
acetyl-4,6,8-trimethylazulene [11b] showed the highest
cytotoxicity and tumor specificity (TS >35.6 and >44.1,
respectively) (21), they inhibited NO production by activated
macrophages very weakly (SI=1.3, ><1.0, respectively) (Table
I). Although compounds [8a, 10a, 2b, 3b] potently inhibited
NO production by activated macrophages (Table I), they
showed very weak tumor-specific cytotoxicity (TS= ><1.8,
><1.4, >2.3, ><1.8) (21). These data indicate that the
biological activities of the trihaloacetylazulenes are not related
to each other. Further studies are required to confirm the anti-
inflammatory action of the trihaloacetylazulenes. 
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Table II. Radical production and scavenging activity of trihaloacetylazulenes.
Compd. Radical intensity at pHa Radical scavenging activity against
4.0 7.4 10.0 13.5 NOb O2–c DPPHd
Control – – – – 2.31 (100) 2.60 (100) 1.60 (100)
[8a] <0.08 <0.08 <0.08 <0.08 1.91 (83) 2.67 (103) 1.07 (67)
[10a] <0.08 <0.08 <0.08 <0.08 1.96 (85) 2.75 (106) 1.51 (95)
[2b] <0.08 <0.08 <0.08 <0.08 1.92 (83) 2.59 (100) 1.32 (83)
[3b] <0.08 <0.08 <0.08 <0.08 2.08 (90) 2.67 (103) 1.40 (88)
aDetermined 40 sec after dissolving the compound (final: 4 mM) in 0.1 M buffer adjusted to the indicated pH; bDetermined 3 min after dissolving
the compound (final 1.5 mM) in the assay buffer from the ratio of the intensity of the first peak of carboxy-PTI to that of MnO, an external
marker; cDetermined 1 min after dissolving the compound (final 1.5 mM) in the assay buffer from the ratio of the intensity of the first peak of
DMPO-OOH to that of MnO; dDetermined at 1 min after dissolving the compound (final 4 mM) in the assay buffer from the ratio of the intensity
of the third peak of DPPH to that of MnO. The number in parenthesis represents percent of the control.
Figure 4. Effect of trihaloacetylazulenes on LPS-stimulated iNOS and
COX-2 mRNA expressions. Raw 264.7 cells were incubated for 24 h with
the indicated concentrations of 3-trifluoroacetylguaiazulene [8a] (A) or
3-methyl-1-trichloroacetylazulene [2b] (B) in the presence of 100 ng/mL
LPS. The RNA was then isolated and the RT-PCR product was applied to
agarose gel electrophoresis and quantified by densitometry. The expression
of iNOS (grey bars) or COX-2 (white bars) mRNA was expressed as the
ratio to that of ‚-actin mRNA. Each value represents the mean from three
independent experiments. N.D., not determined.
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